Kazakhstan to produce Russian vaccine against Covid-19

Source : 112 Ukraine

Tokayev and Putin agreed to activate the cooperation in the fight against coronavirus
13:40, 17 November 2020

Open source

The production of the Russian vaccine against coronavirus will open in Kazakhstan as RBK reported citing Kazakhstani President Kassym-Jomart Tokayev.

“I reached the agreement with the president of Russia on the construction of the plant for the production of the Russian vaccine. The government has already proceeded to the negotiations on the involvement of the investments in this necessary project,” Tokayev said.

Related: Turkey intends to produce Sputnik V vaccine at its facilities

Last week, the president of Kazakhstan held phone talks with Russia’s President Vladimir Putin. They agreed to activate the cooperation in the fight against coronavirus, ‘including the plans on the organization of the joint production of the vaccine in the territory of Kazakhstan’.

On August 11, President of Russia Vladimir Putin reported that the first vaccine against coronavirus was registered in Russia.

The vaccine would be produced by N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology and the Russian Binnopharm Company. According to Murashko, currently, they finalize technical regulations for scaling production at a number of Russian companies.

Related: WHO could add Russia's Sputnik V to list of recommended vaccines

However, the WHO doubted the safety of the Russian vaccine against Covid-19.

Earlier, the Health Ministry of Russia publicly released the first batch of Sputnik V vaccine against the coronavirus.

Meanwhile, Russian leader Vladimir Putin does not rule out that his country could provide supplies of Sputnik-V vaccine to Ukraine. He said so during his meeting with Viktor Medvedchuk, the Chairman of Political Council of Opposition Platform-For Life party.

Related: Moderna announces approximate cost of its Covid-19 vaccine

On November 11, it was reported that the effectiveness of the Russian Sputnik V vaccine against coronavirus made 92% on the results of the interim analysis of the data of the third phase of the clinical trial.


Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more